The purpose of this study is to test how safe and effective Volrustomig is when combined with other cancer treatments for people with specific types of tumors, specifically in the lung(s). The goal is to see if this combination can help treat the tumors better while being safe for patients.

Are you newly diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) and looking for treatment options? Our study is evaluating new therapies specifically designed for patients with these conditions. If you have not previously tried an anti-cancer therapy for AML/MDS, this study might be for you!

Do you identify as a Black youth? Are you between the ages of 13 and 19? Have you had thoughts on giving up on life? If so, you may be able to participate in a study on a program about preventing suicide for Black youth and their caregivers. We hope this program can make a positive impact on their lives. Compensation is provided.

Do you have a solid tumor that has progressed on other treatments? Do you have at least one measurable tumor? If so, you may be able to take part in a study to improve treatment for advanced solid tumors. We are exploring how safe and effective a combination of drugs is.

In this study, researchers want to find out the highest safe dose of a drug called [212Pb]VMT-α-NET that can be used to treat neuroendocrine tumors.

Do you have a history of breast cancer? Are you done with active breast cancer treatment? Do you live in North Carolina? You may be able to participate in a research study that seeks to understand how different factors have impacted people's emotional well-being during the breast cancer survivorship period. Compensation provided

Have you been diagnosed with Severe Aplastic Anemia (SAA), but don't have a matched sibling donor? If so, you may be able to take part in a study to see if a bone marrow transplant from a donor that is not related can help treat your disease. Compensation provided.

Have you been diagnosed with cancer? If so, you may have the opportunity to participate in a research study designed to examine how central oncology navigation affects the use of supportive care services. Additionally, the study will assess whether enrollment in non-treatment clinical trials increases with the implementation of an Oncology Navigation Resource (ORN) intervention.

This study looks at why there is a large gap in academic achievement between Black and white students in public school districts located in college towns. To find answers, researchers will conduct detailed interviews with current and former teachers, school leaders, parents, and former students in the district of study. Through analysis of these interviews, the study aims to understand what factors from the past and present maintain racial inequality in the school district of study. The findings will help shed light on the causes of racial differences in educational outcomes and suggest ways to make education more equitable in public school districts located in college towns.

In this study, we want to see how well a new drug called Quizartinib works for people with Leukemia who do not have a specific mutation called FLT3-ITD. We want to see if this new drug helps improve the condition.